609 related articles for article (PubMed ID: 26092263)
1. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
Donkers HW; Hautvast JL; Akkermans RP; Swaan CM; Ruijs WL; Hulscher ME
BMC Public Health; 2015 Jun; 15():575. PubMed ID: 26092263
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of mumps and MMR vaccination among university students in England: an online survey.
Bolton-Maggs D; Conrad D; Keenan A; Lamden K; Ghebrehewet S; Vivancos R
Vaccine; 2012 Jul; 30(34):5081-5. PubMed ID: 22705081
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
[TBL] [Abstract][Full Text] [Related]
4. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
5. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
6. Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.
Shah M; Quinlisk P; Weigel A; Riley J; James L; Patterson J; Hickman C; Rota PA; Stewart R; Clemmons N; Kalas N; Cardemil C;
Clin Infect Dis; 2018 Jan; 66(1):81-88. PubMed ID: 29020324
[TBL] [Abstract][Full Text] [Related]
7. Measles, mumps, rubella and varicella antibodies among international and domestic university students.
Dyda A; Broome A; Rawlinson W; Mahimbo A; Saha A; Kefalas B; Seale H; Macintyre CR; Zwar N; Gidding HF; Heywood AE
J Travel Med; 2024 Jan; 31(1):. PubMed ID: 38195239
[TBL] [Abstract][Full Text] [Related]
8. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
[TBL] [Abstract][Full Text] [Related]
10. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
[TBL] [Abstract][Full Text] [Related]
11. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.
Woudenberg T; van der Maas NAT; Knol MJ; de Melker H; van Binnendijk RS; Hahné SJM
J Infect Dis; 2017 Apr; 215(8):1181-1187. PubMed ID: 28368471
[TBL] [Abstract][Full Text] [Related]
13. MMR vaccination and disease elimination: the Finnish experience.
Davidkin I; Kontio M; Paunio M; Peltola H
Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
[TBL] [Abstract][Full Text] [Related]
14. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
Nic Lochlainn LM; Woudenberg T; van Lier A; Zonnenberg I; Philippi M; de Melker HE; Hahné SJM
Vaccine; 2017 Oct; 35(43):5828-5834. PubMed ID: 28923422
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD
Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446
[TBL] [Abstract][Full Text] [Related]
16. Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed.
Chamat S; Salameh P; Haddad N; Berry A; Chedid P; Bouharoun-Tayoun H
J Infect Public Health; 2011 Aug; 4(3):125-34. PubMed ID: 21843858
[TBL] [Abstract][Full Text] [Related]
17. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
Lazar M; Stănescu A; Penedos AR; Pistol A
Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
[TBL] [Abstract][Full Text] [Related]
19. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.
Hyle EP; Rao SR; Bangs AC; Gastañaduy P; Fiebelkorn AP; Hagmann SHF; Walker AT; Walensky RP; Ryan ET; LaRocque RC
JAMA Pediatr; 2020 Feb; 174(2):e194515. PubMed ID: 31816033
[TBL] [Abstract][Full Text] [Related]
20. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
Béraud G; Abrams S; Beutels P; Dervaux B; Hens N
Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
